Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
Identifieur interne : 004321 ( Main/Merge ); précédent : 004320; suivant : 004322Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
Auteurs : Paola Loria [Italie] ; Amedeo Lonardo ; Giovanni TargherSource :
- Clinical science (London, England : 1979) [ 1470-8736 ] ; 2008.
Descripteurs français
- KwdFr :
- MESH :
- physiopathologie : Athérosclérose, Stéatose hépatique, Système endocrine.
- étiologie : Athérosclérose, Stéatose hépatique, Syndrome métabolique X.
- Facteurs de risque, Femelle, Humains, Mâle, Métabolisme des lipides.
English descriptors
- KwdEn :
- MESH :
- etiology : Atherosclerosis, Fatty Liver, Metabolic Syndrome X.
- physiopathology : Atherosclerosis, Endocrine System, Fatty Liver.
- Female, Humans, Lipid Metabolism, Male, Risk Factors.
Abstract
NAFLD (non-alcoholic fatty liver disease) encompasses the spectrum of fatty liver disease in insulin-resistant individuals who often display T2DM (Type 2 diabetes mellitus) and obesity. The present review highlights the pathophysiological basis and clinical evidence for a possible causal linkage between NAFLD and CVD (cardiovascular disease). The role of traditional and non-traditional CVD risk factors in the pathophysiology of NAFLD is considered in the first part of the review, with the basic science shared by atherogenesis and hepatic steatogenesis discussed in depth in the second part. In conclusion, NAFLD is not an innocent bystander, but a major player in the development and progression of CVD. NAFLD and CVD also share similar molecular mechanisms and targeted treatment strategies. On the research side, studies should focus on interventions aimed at restoring energy homoeostasis in lipotoxic tissues and at improving hepatic (micro)vascular blood supply.
DOI: 10.1042/CS20070311
PubMed: 19016656
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000133
- to stream PubMed, to step Curation: 000133
- to stream PubMed, to step Checkpoint: 000131
- to stream Ncbi, to step Merge: 000064
- to stream Ncbi, to step Curation: 000062
- to stream Ncbi, to step Checkpoint: 000062
Links to Exploration step
pubmed:19016656Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.</title><author><name sortKey="Loria, Paola" sort="Loria, Paola" uniqKey="Loria P" first="Paola" last="Loria">Paola Loria</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Metabolism, Endocrinology and Geriatrics, University of Modena and Reggio Emilia, Modena, Italy. loria.paola@unimore.it</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Internal Medicine, Metabolism, Endocrinology and Geriatrics, University of Modena and Reggio Emilia, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Lonardo, Amedeo" sort="Lonardo, Amedeo" uniqKey="Lonardo A" first="Amedeo" last="Lonardo">Amedeo Lonardo</name></author><author><name sortKey="Targher, Giovanni" sort="Targher, Giovanni" uniqKey="Targher G" first="Giovanni" last="Targher">Giovanni Targher</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="doi">10.1042/CS20070311</idno><idno type="RBID">pubmed:19016656</idno><idno type="pmid">19016656</idno><idno type="wicri:Area/PubMed/Corpus">000133</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000133</idno><idno type="wicri:Area/PubMed/Curation">000133</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000133</idno><idno type="wicri:Area/PubMed/Checkpoint">000131</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000131</idno><idno type="wicri:Area/Ncbi/Merge">000064</idno><idno type="wicri:Area/Ncbi/Curation">000062</idno><idno type="wicri:Area/Ncbi/Checkpoint">000062</idno><idno type="wicri:Area/Main/Merge">004321</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.</title><author><name sortKey="Loria, Paola" sort="Loria, Paola" uniqKey="Loria P" first="Paola" last="Loria">Paola Loria</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Metabolism, Endocrinology and Geriatrics, University of Modena and Reggio Emilia, Modena, Italy. loria.paola@unimore.it</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Internal Medicine, Metabolism, Endocrinology and Geriatrics, University of Modena and Reggio Emilia, Modena</wicri:regionArea><wicri:noRegion>Modena</wicri:noRegion></affiliation></author><author><name sortKey="Lonardo, Amedeo" sort="Lonardo, Amedeo" uniqKey="Lonardo A" first="Amedeo" last="Lonardo">Amedeo Lonardo</name></author><author><name sortKey="Targher, Giovanni" sort="Targher, Giovanni" uniqKey="Targher G" first="Giovanni" last="Targher">Giovanni Targher</name></author></analytic><series><title level="j">Clinical science (London, England : 1979)</title><idno type="eISSN">1470-8736</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Atherosclerosis (etiology)</term><term>Atherosclerosis (physiopathology)</term><term>Endocrine System (physiopathology)</term><term>Fatty Liver (etiology)</term><term>Fatty Liver (physiopathology)</term><term>Female</term><term>Humans</term><term>Lipid Metabolism</term><term>Male</term><term>Metabolic Syndrome X (etiology)</term><term>Risk Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Athérosclérose (physiopathologie)</term><term>Athérosclérose (étiologie)</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Métabolisme des lipides</term><term>Stéatose hépatique (physiopathologie)</term><term>Stéatose hépatique (étiologie)</term><term>Syndrome métabolique X (étiologie)</term><term>Système endocrine (physiopathologie)</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Atherosclerosis</term><term>Fatty Liver</term><term>Metabolic Syndrome X</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Athérosclérose</term><term>Stéatose hépatique</term><term>Système endocrine</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Atherosclerosis</term><term>Endocrine System</term><term>Fatty Liver</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Athérosclérose</term><term>Stéatose hépatique</term><term>Syndrome métabolique X</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Lipid Metabolism</term><term>Male</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Métabolisme des lipides</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">NAFLD (non-alcoholic fatty liver disease) encompasses the spectrum of fatty liver disease in insulin-resistant individuals who often display T2DM (Type 2 diabetes mellitus) and obesity. The present review highlights the pathophysiological basis and clinical evidence for a possible causal linkage between NAFLD and CVD (cardiovascular disease). The role of traditional and non-traditional CVD risk factors in the pathophysiology of NAFLD is considered in the first part of the review, with the basic science shared by atherogenesis and hepatic steatogenesis discussed in depth in the second part. In conclusion, NAFLD is not an innocent bystander, but a major player in the development and progression of CVD. NAFLD and CVD also share similar molecular mechanisms and targeted treatment strategies. On the research side, studies should focus on interventions aimed at restoring energy homoeostasis in lipotoxic tissues and at improving hepatic (micro)vascular blood supply.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004321 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004321 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Lorraine
|area= InforLorV4
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:19016656
|texte= Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:19016656" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a InforLorV4
| This area was generated with Dilib version V0.6.33. |  |